Home » Topics » BioWorld Science

BioWorld Science
RSS

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

Superoxide ion production inhibitors from Sagami

Aug. 30, 1996

VLA-4 receptor-blocking drugs described by Zeneca

Aug. 30, 1996

Protease inhibitors described by Shionogi

Aug. 30, 1996

Gene mutancy linked to natural HIV-1 infection resistance

Aug. 30, 1996

Genetic sequence of AIDS-related disease revealed

Aug. 30, 1996

Cytel receives phase I SBIR grant for AIDS vaccine development

Aug. 30, 1996

Paracelsian improves HIV-1 system model

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.